Extension of Time to File SOU

ADUHELM

Biogen MA Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88841987
LAW OFFICE ASSIGNED LAW OFFICE 126
MARK SECTION
MARK http://uspto.report/TM/88841987/mark.png (stylized and/or with design)
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
OWNER SECTION (current)
NAME Biogen MA Inc.
MAILING ADDRESS 225 Binney Street
CITY Cambridge
STATE Massachusetts
ZIP/POSTAL CODE 02142
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Biogen MA Inc.
MAILING ADDRESS 225 Binney Street
CITY Cambridge
STATE Massachusetts
ZIP/POSTAL CODE 02142
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Douglas A. Rettew
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docketing@finnegan.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) takisha.diaz@finnegan.com
CORRESPONDENCE INFORMATION (proposed)
NAME Douglas A. Rettew
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docketing@finnegan.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) takisha.diaz@finnegan.com
DOCKET/REFERENCE NUMBER 14726.0080
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of Alzheimer's disease
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 09/08/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /william shaw/
SIGNATORY'S NAME William Shaw
SIGNATORY'S POSITION IP Counsel, Biogen MA Inc.
DATE SIGNED 03/03/2021
SIGNATORY'S PHONE NUMBER Contact attorney of record, 202-408-4000
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Wed Mar 03 16:40:12 ET 2021
TEAS STAMP USPTO/ESU-XX.XXX.X.X-2021
0303164012652292-88841987
-770667270e09deb7fdc3e5d0
fc3f4a31a6d88fb65d89742c5
dcfe4ff3e64b721b-CC-40092
613-20210302134234946267



PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: ADUHELM (stylized and/or with design, see http://uspto.report/TM/88841987/mark.png)
SERIAL NUMBER: 88841987

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Biogen MA Inc., having an address of
      225 Binney Street
      Cambridge, Massachusetts 02142
      United States
      Email: XXXX
Proposed: Biogen MA Inc., having an address of
      225 Binney Street
      Cambridge, Massachusetts 02142
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 09/08/2020.

For International Class 005:
Current identification: Pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of Alzheimer's disease

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Douglas A. Rettew
      PRIMARY EMAIL FOR CORRESPONDENCE: docketing@finnegan.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): takisha.diaz@finnegan.com

Correspondence Information (proposed):
      Douglas A. Rettew
      PRIMARY EMAIL FOR CORRESPONDENCE: docketing@finnegan.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): takisha.diaz@finnegan.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /william shaw/      Date Signed: 03/03/2021
Signatory's Name: William Shaw
Signatory's Position: IP Counsel, Biogen MA Inc.
Signatory's Phone: Contact attorney of record, 202-408-4000
Signature method: Sent to third party for signature

PAYMENT: 88841987
PAYMENT DATE: 03/03/2021

Serial Number: 88841987
Internet Transmission Date: Wed Mar 03 16:40:12 ET 2021
TEAS Stamp: USPTO/ESU-XX.XXX.X.X-2021030316401265229
2-88841987-770667270e09deb7fdc3e5d0fc3f4
a31a6d88fb65d89742c5dcfe4ff3e64b721b-CC-
40092613-20210302134234946267




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed